Caleb Rans

Contributing Writer https://www.neurologyadvisor.com

Caleb Rans is a clinical pharmacist and medical communications specialist with professional expertise in medical writing, editing, and contract clinical research. He holds a PharmD from the University of Alberta and presently resides in Vancouver, Canada. He currently works as an independent consultant for several news, CME, and pharmaceutical companies.

All articles by Caleb Rans

Sleep Disorders

Short Sleep Duration Linked to Emotional and Behavioral Symptoms in Children

Caleb Rans

January 21, 2020

In boys but not girls, reduced sleep duration at age 8 and 10 years predicted the development of behavioral disorder symptoms 2 years later.

Neurobehavioral Disorders

Insomnia, Sleep Disturbances Common Among Veterans With PTSD

Caleb Rans

January 16, 2020

The researchers analyzed data from 1649 combat-exposed United States military veterans who were evaluated at a Veterans Affairs facility between 2009 and 2012 after deployment to the wars in Iraq and/or Afghanistan.

Neurobehavioral Disorders

Atorvastatin Does Not Influence Cognition or Mood in Bipolar and Depressive Disorders

Caleb Rans

December 30, 2019

Researchers sought to address the possible link between cognitive or mood symptoms and statins.

Person holding pillow over their face trying to sleep

Sleep Disorders

Impaired Sleep Observed in Adults With Autism Spectrum Disorder

Caleb Rans

December 20, 2019

The researchers found that adults with ASD showed significant impairments in both objective and subjective measures of sleep compared with controls.

Alzheimer's Disease and Dementia

Acetylcholinesterase Inhibitors May Reduce Psychotropic Prescriptions in Alzheimer Disease

Caleb Rans

August 1, 2019

Use of acetylcholinesterase inhibitors to manage dementia-related behavioral and psychological symptoms in people with Alzheimer disease may reduce the need for psychotropic medications.

Movement Disorders

Valbenazine Improves Overall Tardive Dyskinesia Severity

Caleb Rans

April 1, 2019

Consistent with primary KINECT 3 study results, supplemental analyses indicate that participants treated with valbenazine had statistically significant improvements in tardive dyskinesia severity.

Next post in Movement Disorders

Caleb Rans

All articles by Caleb Rans

Short Sleep Duration Linked to Emotional and Behavioral Symptoms in Children

Insomnia, Sleep Disturbances Common Among Veterans With PTSD

Atorvastatin Does Not Influence Cognition or Mood in Bipolar and Depressive Disorders

Impaired Sleep Observed in Adults With Autism Spectrum Disorder

Acetylcholinesterase Inhibitors May Reduce Psychotropic Prescriptions in Alzheimer Disease

Valbenazine Improves Overall Tardive Dyskinesia Severity

REM Sleep Behavior Disorder Linked to Clinical Progression of Parkinson Disease